{
  "id": "2be33ea60e264f6b",
  "title": "Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen ( DYNE - 101 ) for Myotonic Dystrophy Type 1",
  "description": "20260120T130000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/dyne-therapeutics-receives-orphan-drug-designation-in-japan-for-zeleciment-basivarsen-dyne-101-for-myotonic-dystrophy-type-1/2261714",
  "published_at": "20260120T130000Z",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/dyne-therapeutics-receives-orphan-drug-designation-in-japan-for-zeleciment-basivarsen-dyne-101-for-myotonic-dystrophy-type-1/2261714",
    "url_mobile": "https://www.manilatimes.net/2026/01/20/tmt-newswire/globenewswire/dyne-therapeutics-receives-orphan-drug-designation-in-japan-for-zeleciment-basivarsen-dyne-101-for-myotonic-dystrophy-type-1/2261714/amp",
    "title": "Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen ( DYNE - 101 ) for Myotonic Dystrophy Type 1",
    "seendate": "20260120T130000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/20/905838.jpg",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}